Pharmacokinetics and pharmacodynamics of inhaled glucocorticoids

Journal of Asthma

Volumn 45, Issue SUPPL. 1, 2008, Pages 13-24

  Padden, Jennifer ^a   Skoner, David ^a   Hochhaus, Gunther ^a  

^a DUQUESNE UNIVERSITY   (United States)

Author keywords

Clearance; Inhaled corticosteroids; Pharmacodynamics; Pharmacokinetics; Protein binding; Pulmonary deposition

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CICLESONIDE; CORTICOSTEROID DERIVATIVE; FLUNISOLIDE; FLUTICASONE FUROATE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MOMETASONE FUROATE; TRIAMCINOLONE ACETONIDE;

ARTICLE; ASTHMA; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG SAFETY; HUMAN; INHALER; METERED DOSE INHALER;

ADMINISTRATION, INHALATION; ANIMALS; DRY POWDER INHALERS; GLUCOCORTICOIDS; HUMANS; LUNG; PROTEIN BINDING;

EID: 58149097541     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900802569942     Document Type: Article

References (8)

1. Tayab ZR, Hochhaus G, Pharmacokinetic/pharmacodynamic evaluation of inhalation drugs: application to targeted pulmonary delivery systems. Expert Opin Drug Deliv 2005; 2(3):519-532.
2. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med. 1998;157(3 Pt 2):S1-53.
3. Leung DY, Bloom JW. Update on glucocorticoid action and resistance. J Allergy Clin Immunol. 2003;111(1):3-22.
4. Allen DB, Bielory L, Derendorf H, Dluhy R, Colice GL, Szefler SJ. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol. 2003;112(3 Suppl):S1-40.
5. Derendorf H. Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety. Respir Med. 1997;91 Suppl A:22-8.
6. Rohatagi S, Arya V, Zech K, Nave R, Hochhaus G, Jensen BK, Barrett JS. Population pharmacokinetics and pharmacodynamics of ciclesonide. J Clin Pharmacol. 2003;43(4):365-78.
7. Daley-Yates PT, Price AC, Sisson JR, Pereira A, Dallow N. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol. 2001;51(5):400-9.
8. Vanden Burgt JA, Busse WW, Martin RJ, Szefler SJ, Donnell D. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol. 2000;106(6):1209-26.